Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 3/2010

01-03-2010 | Brief Report

Invasive group A streptococcal infection in children: clinical manifestations and molecular characterization in a French pediatric tertiary care center

Authors: S. Henriet, F. Kaguelidou, P. Bidet, M. Lorrot, A. De Lauzanne, S. Dauger, F. Angoulvant, J.-C. Mercier, C. Alberti, E. Bingen, A. Faye

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 3/2010

Login to get access

Abstract

Invasive group A streptococcal (GAS) infections have a broad and evolving clinical spectrum, associated with various GAS genotypes and/or virulence factors that are only poorly described in children. We aimed to assess the clinical and molecular characteristics of invasive GAS infections in 28 children admitted from 2000 to 2007 at a large French pediatric tertiary care center. The GAS isolates were characterized molecularly by emm-typing and by the determination of the main virulence factors: speA, speB, speC, smeZ-1, ssa, sic, and silC. The median age of the children was 2.9 years. Osteoarticular infection (OAI) was the main clinical manifestation (n = 15/28, 53%). emm-1 predominated (n = 10/28), followed by emm-12, 3, and 4. No significant correlation was found between emm type and clinical manifestations, but emm-1 predominated in cases of OAI (n = 7/15) and was associated with speA, speB, smeZ-1, and sic virulence factor genes. In this pediatric study, we describe a predominance of OAI associated with emm-1 GAS. Further larger international pediatric studies, including host immunity evaluation, are needed in order to better assess the pathogenesis of GAS infection in children.
Literature
1.
go back to reference Cunningham MW (2000) Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13(3):470–511CrossRefPubMed Cunningham MW (2000) Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13(3):470–511CrossRefPubMed
2.
go back to reference Cimolai N, Trombley C, Adderley RJ, Tredwell SJ (1992) Invasive Streptococcus pyogenes infections in children. Can J Public Health 83(3):230–233PubMed Cimolai N, Trombley C, Adderley RJ, Tredwell SJ (1992) Invasive Streptococcus pyogenes infections in children. Can J Public Health 83(3):230–233PubMed
3.
go back to reference Davies HD, Matlow A, Scriver SR, Schlievert P, Lovgren M, Talbot JA et al (1994) Apparent lower rates of streptococcal toxic shock syndrome and lower mortality in children with invasive group A streptococcal infections compared with adults. Pediatr Infect Dis J 13(1):49–56PubMedCrossRef Davies HD, Matlow A, Scriver SR, Schlievert P, Lovgren M, Talbot JA et al (1994) Apparent lower rates of streptococcal toxic shock syndrome and lower mortality in children with invasive group A streptococcal infections compared with adults. Pediatr Infect Dis J 13(1):49–56PubMedCrossRef
4.
go back to reference Mulla ZD (2007) Clinical and epidemiologic features of invasive group A streptococcal infections in children. Pediatr Int 49(3):355–358CrossRefPubMed Mulla ZD (2007) Clinical and epidemiologic features of invasive group A streptococcal infections in children. Pediatr Int 49(3):355–358CrossRefPubMed
5.
go back to reference Beall B, Facklam R, Thompson T (1996) Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol 34(4):953–958PubMed Beall B, Facklam R, Thompson T (1996) Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol 34(4):953–958PubMed
6.
go back to reference Schmitz FJ, Beyer A, Charpentier E, Normark BH, Schade M, Fluit AC et al (2003) Toxin-gene profile heterogeneity among endemic invasive European group A streptococcal isolates. J Infect Dis 188(10):1578–1586CrossRefPubMed Schmitz FJ, Beyer A, Charpentier E, Normark BH, Schade M, Fluit AC et al (2003) Toxin-gene profile heterogeneity among endemic invasive European group A streptococcal isolates. J Infect Dis 188(10):1578–1586CrossRefPubMed
7.
go back to reference Bidet P, Courroux C, Salgueiro C, Carol A, Mariani-Kurkdjian P, Bonacorsi S et al (2007) Molecular epidemiology of the sil streptococcal invasive locus in group A streptococci causing invasive infections in French children. J Clin Microbiol 45(6):2002–2004CrossRefPubMed Bidet P, Courroux C, Salgueiro C, Carol A, Mariani-Kurkdjian P, Bonacorsi S et al (2007) Molecular epidemiology of the sil streptococcal invasive locus in group A streptococci causing invasive infections in French children. J Clin Microbiol 45(6):2002–2004CrossRefPubMed
8.
go back to reference Darenberg J, Luca-Harari B, Jasir A, Sandgren A, Pettersson H, Schalén C et al (2007) Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Clin Infect Dis 45(4):450–458CrossRefPubMed Darenberg J, Luca-Harari B, Jasir A, Sandgren A, Pettersson H, Schalén C et al (2007) Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Clin Infect Dis 45(4):450–458CrossRefPubMed
9.
go back to reference Rivera A, Rebollo M, Miró E, Mateo M, Navarro F, Gurguí M et al (2006) Superantigen gene profile, emm type and antibiotic resistance genes among group A streptococcal isolates from Barcelona, Spain. J Med Microbiol 55(Pt 8):1115–1123CrossRefPubMed Rivera A, Rebollo M, Miró E, Mateo M, Navarro F, Gurguí M et al (2006) Superantigen gene profile, emm type and antibiotic resistance genes among group A streptococcal isolates from Barcelona, Spain. J Med Microbiol 55(Pt 8):1115–1123CrossRefPubMed
10.
go back to reference Minodier P, Bidet P, Rallu F, Tapiero B, Bingen E, Ovetchkine P (2009) Clinical and microbiologic characteristics of group A streptococcal necrotizing fasciitis in children. Pediatr Infect Dis J 28(6):541–543CrossRefPubMed Minodier P, Bidet P, Rallu F, Tapiero B, Bingen E, Ovetchkine P (2009) Clinical and microbiologic characteristics of group A streptococcal necrotizing fasciitis in children. Pediatr Infect Dis J 28(6):541–543CrossRefPubMed
11.
go back to reference Lamagni TL, Darenberg J, Luca-Harari B, Siljander T, Efstratiou A, Henriques-Normark B et al (2008) Epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 46(7):2359–2367CrossRefPubMed Lamagni TL, Darenberg J, Luca-Harari B, Siljander T, Efstratiou A, Henriques-Normark B et al (2008) Epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 46(7):2359–2367CrossRefPubMed
12.
go back to reference Lesko SM, O’Brien KL, Schwartz B, Vezina R, Mitchell AA (2001) Invasive group A streptococcal infection and nonsteroidal antiinflammatory drug use among children with primary varicella. Pediatrics 107(5):1108–1115CrossRefPubMed Lesko SM, O’Brien KL, Schwartz B, Vezina R, Mitchell AA (2001) Invasive group A streptococcal infection and nonsteroidal antiinflammatory drug use among children with primary varicella. Pediatrics 107(5):1108–1115CrossRefPubMed
13.
go back to reference O’Loughlin RE, Roberson A, Cieslak PR, Lynfield R, Gershman K, Craig A et al (2007) The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000–2004. Clin Infect Dis 45(7):853–862CrossRefPubMed O’Loughlin RE, Roberson A, Cieslak PR, Lynfield R, Gershman K, Craig A et al (2007) The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000–2004. Clin Infect Dis 45(7):853–862CrossRefPubMed
14.
go back to reference Factor SH, Levine OS, Harrison LH, Farley MM, McGeer A, Skoff T et al (2005) Risk factors for pediatric invasive group A streptococcal disease. Emerg Infect Dis 11(7):1062–1066PubMed Factor SH, Levine OS, Harrison LH, Farley MM, McGeer A, Skoff T et al (2005) Risk factors for pediatric invasive group A streptococcal disease. Emerg Infect Dis 11(7):1062–1066PubMed
15.
go back to reference Lamagni TL, Efstratiou A, Vuopio-Varkila J, Jasir A, Schalén C (2005) The epidemiology of severe Streptococcus pyogenes associated disease in Europe. Euro Surveill 10(9):179–184PubMed Lamagni TL, Efstratiou A, Vuopio-Varkila J, Jasir A, Schalén C (2005) The epidemiology of severe Streptococcus pyogenes associated disease in Europe. Euro Surveill 10(9):179–184PubMed
16.
go back to reference Stevens DL (1992) Invasive group A streptococcus infections. Clin Infect Dis 14(1):2–11PubMed Stevens DL (1992) Invasive group A streptococcus infections. Clin Infect Dis 14(1):2–11PubMed
17.
go back to reference O’Brien KL, Beall B, Barrett NL, Cieslak PR, Reingold A, Farley MM et al (2002) Epidemiology of invasive group a streptococcus disease in the United States, 1995–1999. Clin Infect Dis 35(3):268–276CrossRefPubMed O’Brien KL, Beall B, Barrett NL, Cieslak PR, Reingold A, Farley MM et al (2002) Epidemiology of invasive group a streptococcus disease in the United States, 1995–1999. Clin Infect Dis 35(3):268–276CrossRefPubMed
18.
go back to reference Vlaminckx BJ, van Pelt W, Schouls LM, van Silfhout A, Mascini EM, Elzenaar CP et al (2005) Long-term surveillance of invasive group A streptococcal disease in The Netherlands, 1994–2003. Clin Microbiol Infect 11(3):226–231CrossRefPubMed Vlaminckx BJ, van Pelt W, Schouls LM, van Silfhout A, Mascini EM, Elzenaar CP et al (2005) Long-term surveillance of invasive group A streptococcal disease in The Netherlands, 1994–2003. Clin Microbiol Infect 11(3):226–231CrossRefPubMed
19.
go back to reference Luca-Harari B, Darenberg J, Neal S, Siljander T, Strakova L, Tanna A et al (2009) Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 47(4):1155–1165CrossRefPubMed Luca-Harari B, Darenberg J, Neal S, Siljander T, Strakova L, Tanna A et al (2009) Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 47(4):1155–1165CrossRefPubMed
20.
go back to reference Vlaminckx BJ, Mascini EM, Schellekens J, Schouls LM, Paauw A, Fluit AC et al (2003) Site-specific manifestations of invasive group a streptococcal disease: type distribution and corresponding patterns of virulence determinants. J Clin Microbiol 41(11):4941–4949CrossRefPubMed Vlaminckx BJ, Mascini EM, Schellekens J, Schouls LM, Paauw A, Fluit AC et al (2003) Site-specific manifestations of invasive group a streptococcal disease: type distribution and corresponding patterns of virulence determinants. J Clin Microbiol 41(11):4941–4949CrossRefPubMed
21.
go back to reference McMillan DJ, Beiko RG, Geffers R, Buer J, Schouls LM, Vlaminckx BJ et al (2006) Genes for the majority of group a streptococcal virulence factors and extracellular surface proteins do not confer an increased propensity to cause invasive disease. Clin Infect Dis 43(7):884–891CrossRefPubMed McMillan DJ, Beiko RG, Geffers R, Buer J, Schouls LM, Vlaminckx BJ et al (2006) Genes for the majority of group a streptococcal virulence factors and extracellular surface proteins do not confer an increased propensity to cause invasive disease. Clin Infect Dis 43(7):884–891CrossRefPubMed
22.
go back to reference Richter SS, Heilmann KP, Beekmann SE, Miller NJ, Miller AL, Rice CL et al (2005) Macrolide-resistant Streptococcus pyogenes in the United States, 2002–2003. Clin Infect Dis 41(5):599–608CrossRefPubMed Richter SS, Heilmann KP, Beekmann SE, Miller NJ, Miller AL, Rice CL et al (2005) Macrolide-resistant Streptococcus pyogenes in the United States, 2002–2003. Clin Infect Dis 41(5):599–608CrossRefPubMed
23.
go back to reference Tanz RR, Shulman ST, Shortridge VD, Kabat W, Kabat K, Cederlund E et al (2004) Community-based surveillance in the United States of macrolide-resistant pediatric pharyngeal group A streptococci during 3 respiratory disease seasons. Clin Infect Dis 39(12):1794–1801CrossRefPubMed Tanz RR, Shulman ST, Shortridge VD, Kabat W, Kabat K, Cederlund E et al (2004) Community-based surveillance in the United States of macrolide-resistant pediatric pharyngeal group A streptococci during 3 respiratory disease seasons. Clin Infect Dis 39(12):1794–1801CrossRefPubMed
Metadata
Title
Invasive group A streptococcal infection in children: clinical manifestations and molecular characterization in a French pediatric tertiary care center
Authors
S. Henriet
F. Kaguelidou
P. Bidet
M. Lorrot
A. De Lauzanne
S. Dauger
F. Angoulvant
J.-C. Mercier
C. Alberti
E. Bingen
A. Faye
Publication date
01-03-2010
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 3/2010
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-009-0854-x

Other articles of this Issue 3/2010

European Journal of Clinical Microbiology & Infectious Diseases 3/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.